Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment

INTRODUCTION: The myelodysplastic syndromes (MDS) are a very heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increase risk of transformation to acute myeloid leukemia (AML). Daunorubicin (DNR) is an indispensable drug for the treatment of MDS and AML. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Dan, Xu, Peipei, Chen, Dangui, Wang, Lili, Zhu, Yudi, Zuo, Yifan, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988587/
https://www.ncbi.nlm.nih.gov/pubmed/32021192
http://dx.doi.org/10.2147/IJN.S233395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988587/
https://www.ncbi.nlm.nih.gov/pubmed/32021192
http://dx.doi.org/10.2147/IJN.S233395

Ejemplares similares